Cancer Family
Malignant Respiratory System Neoplasm
CI-CAN-00000249Explore in graph →
2,650 active trials51 approved drugs619 evidence items
- NCIt
- C4571
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000249Explore in graph →
Clinical trials
11,128 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,492)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07053215 | Efficacy of Argon-Helium Cryoablation Plus PD-1 Inhibitors in NSCLC | completed | N/A | 60 | The First Hospital of Hebei Medical UniversityOTHER | 1 | Jul 8, 2025 | clinicaltrials |
| NCT05884099 | Intercostal Cryoanalgesia for Chronic Pain After VATS Lung Resection(CRYO-VATS-2) | completed | N/A | 80 | Centre hospitalier de l'Université de Montréal (CHUM)OTHER | 1 | Jul 4, 2025 |
| clinicaltrials |
| NCT03382561 | Cisplatin/Carboplatin and Etoposide With or Without Nivolumab in Treating Patients With Extensive Stage Small Cell Lung Cancer | completed | Phase 2 | 160 | National Cancer Institute (NCI)NIH | 1 | Jul 3, 2025 | clinicaltrials |
| NCT07049237 | Evidence-Based Nursing for Fatigue and Quality of Life in Lung Cancer Chemotherapy | completed | N/A | 150 | The First Hospital of Hebei Medical UniversityOTHER | 1 | Jul 3, 2025 | clinicaltrials |
| NCT07049250 | Evidence-Based Nursing for Psychological Resilience in Lung Cancer Chemotherapy Patients | completed | N/A | 142 | The First Hospital of Hebei Medical UniversityOTHER | 1 | Jul 3, 2025 | clinicaltrials |
| NCT07050979 | Goal-Directed Fluid Therapy for Thoracoscopic Lobectomy | completed | N/A | 80 | Cukurova UniversityOTHER | 1 | Jul 3, 2025 | clinicaltrials |
| NCT00540982 | Vinorelbine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Treatment and Liver Dysfunction | completed | Phase 1 / Phase 2 | 47 | City of Hope Medical CenterOTHER | 1 | Jul 2, 2025 | clinicaltrials |
| NCT04616768 | PROStep: A Feasibility Trial Using PROs and Step Data to Monitor Patients With Lung and GI Cancers(PROStep) | completed | Phase 3 | 108 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Jul 2, 2025 | clinicaltrials |
| NCT04678440 | [18F]F-AraG/Total Body PET Imaging and Healthy Subjects and Lung Cancer Patients | completed | Early Phase 1 | 5 | University of California, DavisOTHER | 1 | Jul 2, 2025 | clinicaltrials |
| NCT02821793 | Expectations and Priorities of Elderly Patients for a First Medical Treatment for Cancer(PRIORITY) | completed | — | 346 | Institut BergoniéOTHER | 1 | Jul 1, 2025 | clinicaltrials |
| NCT04400188 | A Study of Fluzoparib (SHR-3162) and Temozolomide With or Without SHR-1316 in Treating Patients With Replapsed Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 25 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Jun 29, 2025 | clinicaltrials |
| NCT02078700 | Feasibility of an Early Palliative Care Intervention for Metastatic Cancer Patients. A Phase 2 Study. | completed | Phase 2 | 40 | Azienda USL Reggio Emilia - IRCCSOTHER_GOV | 1 | Jun 25, 2025 | clinicaltrials |
| NCT02191891 | Xentuzumab (BI 836845) Plus Afatinib in Patients With Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC) | completed | Phase 1 | 32 | Boehringer IngelheimINDUSTRY | 4 | Jun 25, 2025 | clinicaltrials |
| NCT04083859 | Digital Outreach Intervention for Lung Cancer Screening(mPATH-Lung) | completed | N/A | 26,998 | Wake Forest University Health SciencesOTHER | 1 | Jun 25, 2025 | clinicaltrials |
| NCT06054152 | CX3CR1+T Cell Predict Immunotherapy Efficacy | completed | — | 150 | Shanghai Pulmonary Hospital, Shanghai, ChinaOTHER | 1 | Jun 25, 2025 | clinicaltrials |
| NCT07036016 | Interstitial Pneumonitis Associated With EGFR-TKI and Combined With PD-1/PD-L1 | completed | — | 67,818 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 0 | Jun 25, 2025 | clinicaltrials |
| NCT02299141 | Nintedanib in Molecularly Selected Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 20 | Washington University School of MedicineOTHER | 1 | Jun 24, 2025 | clinicaltrials |
| NCT06826677 | REAL-WORLD DURVALUMAB IN EXTENSIVE-STAGE SMALL CELL LUNG CANCER(ARAL) | completed | — | 71 | AstraZenecaINDUSTRY | 1 | Jun 24, 2025 | clinicaltrials |
| NCT03267524 | Walking for Recovery From Surgery in Improving Quality of Life in Older Adults With Lung or Gastrointestinal Cancer and Their Family Caregivers | completed | N/A | 87 | City of Hope Medical CenterOTHER | 1 | Jun 22, 2025 | clinicaltrials |
| NCT03885765 | Complication and Lung Function Impairment Prediction Using Perfusion and CT Air Trapping(CLIPPCAIR) | completed | — | 160 | University Hospital, MontpellierOTHER | 1 | Jun 22, 2025 | clinicaltrials |
| NCT00981058 | First-line Treatment of Participants With Stage IV Squamous Non-Small Cell Lung Cancer With Necitumumab and Gemcitabine-Cisplatin(SQUIRE) | completed | Phase 3 | 1,093 | Eli Lilly and CompanyINDUSTRY | 26 | Jun 18, 2025 | clinicaltrials |
| NCT02705820 | Switch Maintenance Pembrolizumab in Patients With NSCLC After First Line Platinum Doublet Chemotherapy(SWIPE) | completed | Phase 2 | 48 | Bank of Cyprus Oncology CentreOTHER | 1 | Jun 17, 2025 | clinicaltrials |
| NCT04314089 | Phase Ib First in Human Dose Escalation of GT103 in Refractory, Advanced Stage Non-Small Cell Lung Cancer (TOP 1902) | completed | Phase 1 | 31 | Edward PatzOTHER | 1 | Jun 17, 2025 | clinicaltrials |
| NCT05435885 | Postoperative Telerehabilitation in Older Adults | completed | N/A | 64 | Pusan National University HospitalOTHER | 1 | Jun 17, 2025 | clinicaltrials |
| NCT05788484 | A Study of CDX-585 in Patients With Advanced Malignancies | completed | Phase 1 | 20 | Celldex TherapeuticsINDUSTRY | 1 | Jun 15, 2025 | clinicaltrials |
| NCT03867175 | Immunotherapy With or Without SBRT in Patients With Stage IV Non-small Cell Lung Cancer | completed | Phase 3 | 5 | Wake Forest University Health SciencesOTHER | 1 | Jun 13, 2025 | clinicaltrials |
| NCT02262325 | Hypofractionated Boost Before Chemoradiation for Patients With Stage II-III Non-small Cell Lung Cancer Unsuitable for Surgery | completed | Phase 2 | 21 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Jun 12, 2025 | clinicaltrials |
| NCT05253053 | To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors | completed | Phase 1 / Phase 2 | 84 | TransThera Sciences (Nanjing), Inc.INDUSTRY | 1 | Jun 12, 2025 | clinicaltrials |
| NCT05342675 | Effect of Rapid Rollover on Pneumothorax After CT-Guided Lung Biopsy | completed | N/A | 54 | University of California, San FranciscoOTHER | 1 | Jun 12, 2025 | clinicaltrials |
| NCT02324296 | PEI REGIMEN: A Therapeutic Option in Small Cell Lung Cancer? A Monoinstitutional Experience of 46 Consecutive Cases | completed | — | 46 | Azienda USL Reggio Emilia - IRCCSOTHER_GOV | 0 | Jun 11, 2025 | clinicaltrials |
| NCT02405273 | Pulmonary Resection And Intensive Rehabilitation(PUREAIR) | completed | N/A | 140 | Azienda USL Reggio Emilia - IRCCSOTHER_GOV | 1 | Jun 11, 2025 | clinicaltrials |
| NCT04731571 | Toward High Fidelity Adaptive Radiotherapy in the Thorax | completed | — | 20 | Henry Ford Health SystemOTHER | 1 | Jun 11, 2025 | clinicaltrials |
| NCT06477211 | DNA Methylation Biomarkers to Predict Survival After Surgery for Lung Adenocarcinoma | completed | — | 292 | Nanjing UniversityOTHER | 1 | Jun 10, 2025 | clinicaltrials |
| NCT07009769 | AI-Driven Precision Diagnostic System for Lung Cancer Based on Liquid Biopsy | completed | — | 865 | Korea University Guro HospitalOTHER | 1 | Jun 8, 2025 | clinicaltrials |
| NCT06600204 | Comparison of SPECT/CT Perfusion and Volumetric CT Volume(VOLSEP) | completed | — | 50 | Central Hospital, Nancy, FranceOTHER | 1 | Jun 6, 2025 | clinicaltrials |
| NCT07005401 | Factors Determine the Feasibility and Surgical Margin Quality of Sublobar Resection for Non-small Cell Lung Cancer? | completed | — | 1,064 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Jun 5, 2025 | clinicaltrials |
| NCT04358237 | Lurbinectedin (PM01183) Combined With Pembrolizumab in Small Cell Lung Cancer.(LUPER) | completed | Phase 1 / Phase 2 | 28 | Antonio Calles BlancoOTHER | 1 | Jun 4, 2025 | clinicaltrials |
| NCT03037385 | Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors(ARROW) | completed | Phase 1 / Phase 2 | 590 | Hoffmann-La RocheINDUSTRY | 13 | May 31, 2025 | clinicaltrials |
| NCT06133816 | Lung Cancer Screening Eligibility Assessment | completed | N/A | 6,125 | Abramson Cancer Center at Penn MedicineOTHER | 1 | May 31, 2025 | clinicaltrials |
| NCT03242915 | Pembrolizumab Plus Chemotherapy in NSCLC With Targetable Genetic Alterations After Progression on Targeted Agents | completed | Phase 2 | 33 | University of Michigan Rogel Cancer CenterOTHER | 1 | May 30, 2025 | clinicaltrials |
| NCT04068896 | Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy | completed | Phase 1 / Phase 2 | 89 | NGM Biopharmaceuticals, IncINDUSTRY | 1 | May 29, 2025 | clinicaltrials |
| NCT05985824 | The Effect of Pranayama Breathing Exercise on Quality of Life in Lung Cancer Patients | completed | N/A | 72 | Sanko UniversityOTHER | 1 | May 29, 2025 | clinicaltrials |
| NCT06208124 | A Study of IMM-6-415 in RAS/RAF Mutant Solid Tumors | completed | Phase 1 / Phase 2 | 30 | Immuneering CorporationINDUSTRY | 1 | May 28, 2025 | clinicaltrials |
| NCT05722847 | Risk Stratification for Patients With Hospital-diagnosed Advanced Lung Cancer | completed | — | 18 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | May 25, 2025 | clinicaltrials |
| NCT05801965 | A Digital Therapeutic Solution for Cancer Patients | completed | N/A | 48 | Sidekick HealthINDUSTRY | 1 | May 25, 2025 | clinicaltrials |
| NCT01652820 | Chemotherapy/Radiotherapy Versus Concomitant Chemotherapy Followed by Radiotherapy in Stage IIIB Non-small Cell Lung Cancer(GECP0008) | completed | Phase 2 | 140 | Spanish Lung Cancer GroupOTHER | 0 | May 23, 2025 | clinicaltrials |
| NCT04314895 | Trial of NanoPac Intratumoral Injection in Lung Cancer | completed | Phase 2 | 18 | NanOlogy, LLCINDUSTRY | 1 | May 23, 2025 | clinicaltrials |
| NCT04774380 | Study of Durvalumab in Combination With Platinum and Etoposide for the First Line Treatment of Patients With Extensive-stage Small Cell Lung Cancer(LUMINANCE) | completed | Phase 3 | 152 | AstraZenecaINDUSTRY | 6 | May 23, 2025 | clinicaltrials |
| NCT04788264 | Exercise Training and Behavioral Modification for the Improvement of Physical Activity in Head and Neck Cancer Patients Undergoing Cancer Treatment | completed | N/A | 12 | Thomas Jefferson UniversityOTHER | 1 | May 22, 2025 | clinicaltrials |
Data updated 24 days agoSource updated Jul 8, 2025source: clinicaltrials